Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Panel Endorses Capivasertib Use in Prostate Cancer

2.

Study finds 81% of cancer cures touted by TikTok videos are fake

3.

The top three drugs for multiple myeloma treatment upfront are four.

4.

More men with prostate cancer are avoiding unnecessary surgery

5.

After HSCT, a longer course of letermovir prophylaxis decreased the risk of cytomegalovirus infection.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot